Stock Information

• Could Tempus AI’s GenoPredicta Data Push Quietly Reshape Its Precision Oncology Edge (TEM)?
  Thu, Apr 16, 2026 12:06 PM
• Tempus AI (TEM) Unveils Cancer Test Kit, Soars 13.9%
  Thu, Apr 16, 2026 1:18 AM
• Tech Leads, Dow Lags As Oil Holds Near $92: What's Moving Markets Wednesday?
  Wed, Apr 15, 2026 1:16 PM
• Tempus AI Stock Jumps 10% After Predicta Collaboration Expansion
  Wed, Apr 15, 2026 12:32 PM
• Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
  Wed, Apr 15, 2026 12:30 PM
• Tempus AI shares are trading higher after the company announced a commercial expansion with Predicta Biosciences of a co-branded whole-genome sequencing assay intended for the comprehensive genomic characterization of hematologic malignancies and measurable residual disease monitoring.
  Wed, Apr 15, 2026 11:48 AM
• Tempus AI, Inc. And Predicta Biosciences Announce Collaboration To Expand Life Sciences Access To Ultrasensitive Whole-Genome Sequencing Assay For Hematologic Malignancies And MRD Monitoring
  Wed, Apr 15, 2026 10:35 AM
• Tempus AI And Predicta Biosciences Announce Commercial Expansion Of Co-Branded WGS Assay Intended For Comprehensive Genomic Characterization Of Hematologic Malignancies And MRD Monitoring
  Wed, Apr 15, 2026 8:38 AM
• Tempus AI, Inc. (TEM) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
  Tue, Apr 14, 2026 5:21 PM
• Tempus AI Stock Jumps As Data Presentations Fuel Fresh AI Oncology Buzz
  Tue, Apr 14, 2026 2:29 PM

Financial data not available